Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07811180 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells - Intensive Care Unit

Name: Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells - Intensive Care Unit — clinical trial record (NCT07811180)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: TORCH-ICU

StatusNot Yet Recruiting

PhaseNot applicable

SponsorVanderbilt University Medical Center

Started2026-11-01

View on ClinicalTrials.gov ↗

Vanderbilt University Medical Center

320 trials monitored

See 25 trials at risk

The purpose of this study is to understand how cells of the immune system use the common sugar glucose during critical illness. Investigators will intravenously infuse a non-radioactive carbon-13 glucose tracer into adult intensive care unit (ICU) participants over a few hours and collect immune cells from the blood to track uptake and usage of this glucose within these immune cells.

Trial Details

NCT Number	NCT07811180
Lead Sponsor	Vanderbilt University Medical Center
Conditions	Glucose, Metabolism, Isotope Labeling, Immune System and Related Disorders, Critical Illness, Intensive Care Unit (ICU), Sepsis
Enrollment	25 participants
Start Date	2026-11-01
Primary Completion	2027-10-31 (estimated)
Study Completion	2028-03-01 (estimated)
Updated on ClinicalTrials.gov	2026-09-09